SUCCESSFUL TREATMENT OF TWO CASES WITH PHILADELPHIA-CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WHO RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND THE TREATMENTS WITH NOVEL IMMUNOTHERAPIES AND PONATINIB

The outcomes of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) resistant to new drugs such as tyrosine kinase inhibitors, inotuzumab ozogamicin (InO) and blinatumomab are dismal.We treated two cases of Ph+ALL resistant to these drugs that achieved long-term survival after treatment with chimeric antigen receptor (CA

It is estimated that 1 in 10 hospital inpatients in Scotland have experienced a medication error.In our unit, an audit in 2019 identified documentation of as-required prescriptions on drug Kardexes as an important target for improvement.This project aimed to reduce the percentage of these errors to <5% in the ward in 6 months.Weekly point preval

Under the impetus of the global industry,the 5G technology developes rapidly and has entered the critical stage of standard setting and technical canals & nubiola cava verification.Based on this,the key technologies of 5G and its latest standardization progress was introduced mainly,including pride empire bowling ball massive MIMO,new radio network

Electroacupuncture (EA) therapy has been widely reported to alleviate neuropathic pain with few side effects in both clinical practice and animal studies worldwide.However, little is known about the comparison of the therapeutic efficacy among the diverse EA schemes used for neuropathic pain.The present study is aimed at investigating the therapeut